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Widespread multifactor interactions present a signiﬁcant challenge in determining risk factors of complex diseases. Several combinato-
rial approaches, such as the multifactor dimensionality reduction (MDR) method, have emerged as a promising tool for better detecting
gene-gene (G 3 G) and gene-environment (G 3 E) interactions. We recently developed a general combinatorial approach, namely the
generalized multifactor dimensionality reduction (GMDR) method, which can entertain both qualitative and quantitative phenotypes
and allows for both discrete and continuous covariates to detect G 3 G and G 3 E interactions in a sample of unrelated individuals. In
this article, we report the development of an algorithm that can be used to study G3G and G3 E interactions for family-based designs,
called pedigree-based GMDR (PGMDR). Compared to the available method, our proposed method has several major improvements,
including allowing for covariate adjustments and being applicable to arbitrary phenotypes, arbitrary pedigree structures, and arbitrary
patterns of missing marker genotypes. Our Monte Carlo simulations provide evidence that the PGMDR method is superior in perfor-
mance to identify epistatic loci compared to the MDR-pedigree disequilibrium test (PDT). Finally, we applied our proposed approach
to a genetic data set on tobacco dependence and found a signiﬁcant interaction between two taste receptor genes (i.e., TAS2R16 and
TAS2R38) in affecting nicotine dependence.Introduction
It is well recognized that joint actions or interactions of
multiple genetic and environmental factors are an impor-
tant biological basis for complex diseases and phenotype
variation.1–8 Ubiquitous interactions likely result in the ef-
fect of any single factor differing in magnitude and/or in
direction, dependent on other genetic variations and envi-
ronmental factors. This makes determining which genetic
polymorphisms and/or environmental factors are associ-
ated with a disease of interest a difﬁcult task. Traditional
strategies attempt to investigate a single factor at a time
and ascribe a phenotype to additive or combinatorial ef-
fects of these factors. These approaches fail to pinpoint de-
terminants that have a weak marginal correlation between
the levels of each individual factor and the phenotype. The
interaction analysis methods established by extending
single factor-based approaches are typically underpowered
to detect high-order interactions because of problems
including heavy computational burden (usually being
computationally intractable), increased type I and II errors,
and being less robust and potentially biased as a result of
highly sparse data in a multifactorial model.1,5 The deter-
mination of gene-gene (epistasis, G 3 G) and gene-envi-
ronment (plastic reaction norms, G 3 E) interactions still
presents one of the most daunting challenges in genetic
epidemiology and new analytical approaches are needed.
Recently emerging combinatorial approaches such as the
multifactor dimensionality reduction method (MDR),9–11
the combinatorial partitioning method (CPM),12 and the
restricted partition method (RPM)13 are promising toolstoward a better identiﬁcation of interactions. To circum-
vent the limitations of the existing combinatorial methods
(e.g., not allowing adjustment for covariates), we recently
developed a comprehensive combinatorial approach for
population-based studies of unrelated individuals, namely
the generalized multifactor dimensionality reduction
(GMDR) method that can entertain both qualitative and
quantitative phenotypes, allow for both discrete and con-
tinuous covariates, and offer more ﬂexibility for a popula-
tion-based study design.14 However, these methods are ap-
plicable only to samples consisting of unrelated subjects or
discordant sib-pairs. Because they are immune to bias and
invalidity in the presence of population heterogeneity,
family-based tests that are conditional on parental infor-
mation are commonly used in human genetic studies. Over
the past decades, a signiﬁcant amount of clinical and ge-
netic data has been collected on nuclear families and/or
multigenerational pedigrees for linkage and family-based
association analysis. Inability to handle family-based data
has greatly limited the applicability of combinatorial
approaches for detecting G 3 G and G 3 E interactions.
Thus, the development of novel algorithms for detecting
G3G andG3 E interactions in family-based study designs
is warranted.
Recently, Martin et al.15 proposed the MDR-pedigree
disequilibrium test (PDT) method, which is applicable to
family-based designs. However, like the original MDR, the
MDR-PDT method does not permit adjustment for covari-
ates such as ethnicity, sex,weight, and/or age and is applica-
ble only todichotomousphenotypes. To tackle these limita-
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generalizedmultifactordimensionality reduction (PGMDR)
method that represents an important extension of our pre-
vious GMDR method for designs that use samples of unre-
lated individuals. Compared to the MDR-PDT method,15
our proposed approach offers three major improvements:
(1)allowingforcovariateadjustment, (2)providingauniﬁed
framework for analyzing both continuous and dichoto-
mous phenotypes, and (3) coherently handling different
family types and sizes as well as patterns of missing data.
In the following sections, we begin by introducing a
general statistic that is sensitive to only within-family asso-
ciation between genotypes at loci under consideration and
a phenotype of interest. Next, we formulate the corre-
sponding PGMDR method by integrating the genotypic-
association statistic into the MDR framework. We conduct
a series of simulations and analyze a real data set to demon-
strate the use of the new method. Finally, we examine
issues such as its relationship to MDR-PDT15 to gain
a deeper insight into the method.
Material and Methods
Test Statistic
In sexual reproduction, haploid sex cells, also called gametes, are
produced from diploid germline cells through a process involving
meiosis. The fusion of two gametes, one egg from the female and
one sperm from themale, known as syngamy or fertilization, gives
rise to a zygote that potentially develops into a new organism.
Each gamete united to form a zygote has a complementary game-
tid, termed nontransmitted gamete, which is produced from the
meiotic division of the primary gametocyte but does not necessar-
ily develop into amature gamete (e.g., polar bodies that eventually
disintegrate during meiosis) or participate in fertilization. We call
the pseudo individual formed by the two nontransmitted gametes
of a zygote the ‘‘pseudo nontransmitted sib.’’
The genotype of the pseudo nontransmitted sib of a nonfounder
at loci of interest, referred to as the nontransmitted genotype
hereafter, can be determined or inferred based on the genotype
information of the nonfounder and the other member(s) in the
pedigree. (We assume here that the genotype of the nonfounder
is always available. If genotype missing occurs in a nonfounder,
we suggest a case-wise deletion of such a nonfounder or using a sta-
tistically imputed genotype based on the ﬂanking markers or hap-
lotypes.) Consider N pedigrees (or families), with ni nonfounders
in pedigree i. Let mij be the genotype of nonfounder j in pedigree
i at the considered loci andmij be the corresponding nontransmit-
ted genotype.When both parental genotypes are observed, we can
easily determine mij. For example, assuming that family i has pa-
rental genotypes AaBb and AaBB and two children, child 1 with
AABb and child 2 with AaBB, then mi1 ¼ aaBB and mi2 ¼ AaBb.
When parental genotype information is missing, we can sample
one realization of the nontransmitted genotype from the condi-
tional distribution given the minimal sufﬁcient statistic for the
null hypothesis through an algorithm that is modiﬁed from
Rabinowitz and Laird16 and applicable to general pedigrees (see
Appendix A). The exhaustive results of the algorithm for conﬁgu-
rations of nuclear families are summarized in the three Appendix
Tables. The nontransmitted genotype at a set of loci can be deter-
mined on the basis of locus by locus.458 The American Journal of Human Genetics 83, 457–467, OctobeLet yij be the phenotype of individual j in pedigree i and t(yij)
be some function of the phenotype, depending on possibly
unknown parameters. Let g(mij) or gðmijÞ be a vector whose
elements are coded for the corresponding marker genotypes.
In what follows we will abbreviate g(mij) as gij, gðmijÞ as gij,
and t(yij) as tij. To measure within-family association between
genotype and phenotype, we deﬁne a general class of statistics
as
sij ¼ tij 

gij  gij

¼ tij  gij þ
tij
  gij: (1)
When gij ¼ gij, sij ¼ 0, that is, when the transmitted and non-
transmitted genotypes are the same, the individual is uninforma-
tive, and thus will be automatically excluded from the subsequent
analysis. For each informative nonfounder, transmitted and non-
transmitted genotypes contribute tij and tij to the corresponding
component in sij so that the nontransmitted genotype virtually
provides a ‘‘pseudo-contrast.’’ Under the null hypothesis of no
association between the genotype and phenotype under investi-
gation, the transmission of either an observed genotype or its
nontransmitted genotype is equally frequent and the expectation
of the test statistic is 0.
For different purposes, we have diverse coding schemes for gð$Þ,
for example, the number of a given allele. To detect genotype-
genotype and genotype-environment interactions, we use the
genotype-coding scheme. We can also use different codings for
t(yij). For example, letting t(yij) ¼ 1 denote an affected subject
and t(yij) ¼ 0 an unaffected or phenotype-unknown subject,
then only affected subjects contribute to the statistics. The valid-
ity of the statistic does not depend on the choice of genotype or
phenotype coding, although the power does. Without loss of
generality, in this article we use the score of generalized linear
models17 or the score-like of quasilikelihood functions18,19 for
t(yij), which allows for covariate adjustment, is applicable to
both continuous and categorical phenotypes, and is potentially
more powerful.
The essential features of the test statistic are ﬂexibility and
generalization, while retaining validity (i.e., being unbiased under
the null hypothesis). By decoupling phenotype coding from the
evaluation of the conditional distribution of the nontransmitted
genotype, the test statisticmay be applied to arbitrary phenotypes,
arbitrary pedigree structures, arbitrary patterns of missing infor-
mation in the founders and even other settings not yet discussed
in the literature, and also allows incorporating covariates. We are
free to use any other association statistic that appears appropriate,
regardless of phenotype distribution, genotype frequencies in
the founder population, sampling design, and ascertainment
process.
The Pedigree-Based GMDR Algorithm
The method proposed here uses the same data-reduction strategy
(a constructive induction approach) as the MDR9,10 and GMDR14
approaches. Speciﬁcally, the possible cells in a multifactor space
are collapsed into two distinct groups according to their statistic
values computed from Equation (1), effectively transforming the
original representation of multiple attributes into that of a new
two-level attribute, and thereby identifying from all potential
combinations the speciﬁc combinations of factors that show the
strongest dichotomous associationwith the phenotype of interest.
The difference is that we consider here each nonfounder as an ob-
served individual together with its nontransmitted control that
are assumed to have opposite statistic values, instead of only ther 10, 2008
observed one in the unrelated-based GMDR method. Beneﬁting
from a comprehensive statistic, the proposed method has the ﬂex-
ibility to incorporate an adjustment for covariates, can handle
missing genotype data, and is applicable to arbitrary pedigree
structures and phenotypes.
To identify and evaluate the best model, we propose using
k-fold crossvalidation. Other choices are also possible within the
same framework of data reduction, e.g., the best classiﬁcation
can be evaluated on the basis of a permutation p value as in
the MDR-PDT.15 In brief, the data-reduction algorithm can be de-
scribed as follows (see Figure S1 available online and Appendix B
for further details). The informative nonfounders, each consisting
of a transmitted genotype at loci of interest and its internal con-
trol, are randomly divided into k nearly equal subsets, and then
the crossvalidation is repeated k times. Each time, one of the k
subsets is used as the testing set and the remaining k1 subsets
are put together to form the training set. The training set is
used to compute the average of the statistic values for all cells de-
ﬁned by a multidimensional space. Each nonempty multifactor
cell is labeled as either ‘‘high risk’’ or ‘‘low risk’’ according to
whether or not its average statistic value exceeds a preassigned
threshold T (e.g., T ¼ 0). High-risk and low-risk cells are pooled
into separate groups, creating a dichotomous model that best
captures the correlation between this set of classiﬁcation factors
and the phenotype. The averages of the statistic values in the
high-risk and the low-risk groups can provide a measure of the
classiﬁcation precision: a larger difference between them repre-
sents a better classiﬁcation. All potential combinations of the
factors are evaluated sequentially for their ability to classify the
statistic values in the training data, and the model that has max-
imum classiﬁcation accuracy is chosen as the best from those
with the same dimensionality. The independent testing set is
used to estimate the prediction ability of the best model selected
for each multifactor dimensionality. The results are averaged and
the consistency of the model is computed across all k trials. Fi-
nally, among this set of best models, we select the model with
maximum prediction accuracy and/or maximum crossvalidation
consistency. We can use a sign test and/or a permutation test
for prediction accuracy to assess the signiﬁcance of an identiﬁed
model.
Simulation Study
To demonstrate the validity and statistical power of the proposed
approach, we performed extensive simulations in a variety of
settings for both dichotomous and continuous phenotypes on
the basis of 600 families. For simplicity of the exposition, we con-
sidered all functional and marker loci to be independent, diallelic,
and at Hardy-Weinberg equilibrium. The functional loci were con-
sidered at two levels of allele frequencies, equifrequency and a
minor allele frequency (MAF) of 0.25, and the marker loci (except
for those coincident with the functional loci) had equifrequent
alleles. Both phenotypes were simulated under the same digenic
espistatic interactionmodels commonly used in recent simulation
studies,9,13,15 called the antidiagonal model (i.e., genotypes AAbb,
AaBb, and aaBB are considered as a high-value group and the rest
as a low-value group) and the checkerboard model (i.e., AABb,
AaBB, Aabb, and aaBb versus the others), in which the marginal
effects of each disease locus are very small or zero. These are
models that on theoretical grounds would be most difﬁcult to
detect and for which there is some known biological basis or
empirical evidence.20–22 A total of 10 marker loci were simulated.The AmericTo assess the type I error rates, the marker loci were simulated to
be completely independent of the functional loci. To
estimate power, the functional loci were speciﬁed as two of the
marker loci.
Phenotypes were generated based on the following generalized
linear model,
lðmiÞ ¼ aþ xibþ zig, (2)
where mi is the expected phenotypic value of individual i, a is the
intercept, b is the genetic effect, xi is the indicator variable equal to
1 for the high-value group and 0 for the others, g is the covariate
effect, zi is the observed covariate value, and l(mi) is an appropriate
link function. For the continuous phenotype, we used the identity
with a stochastic component assumed to have a normal distribu-
tion for the continuous phenotype, and for the dichotomous phe-
notype the logistic penetrance function. We assumed a ¼ 5.29
and b ¼ 1.09 for the dichotomous phenotype so that the high-
risk genotypes have a penetrance of ~0.015 and the others have
a risk of ~0.005 in the absence of a covariate. The covariate with
g ¼ 1 was assumed to come from a normal distribution with
mean 0 and variance 10; after adding the covariate, the relative
risk is ~1.70: the mean risk rates of the high-risk group and of
the low-risk group are ~0.124 and ~0.073, respectively. The contin-
uous phenotypes were generated at a ¼ 0, b ¼ 0.25, and normal
deviations with mean 0 and variance 1. The covariate with g ¼ 1
was assumed to have a normal distribution with mean 0 and
variance 1. We assumed that all covariate values were available
for all study subjects.
If a sibling was affected for a dichotomous phenotype, or had
a quantitative disease phenotypic value of 2.0 or more extreme
(i.e., being in the ~10% upper tail of the phenotype distribution
varying with the genotype frequencies), we considered him/her
as a proband. The families with a proband and a full-sib who
also reached the phenotypic criterion for proband status were in-
cluded in the study. Once a family met the conditions for enroll-
ment, two additional family members (siblings and/or parents)
were also included into the study, regardless of phenotype. A total
of 600 families—200 families with both parents plus two siblings,
200 with one parent plus three siblings, and 200 with four siblings
and no parent—were simulated according to the sampling scheme
described above.
The nontransmitted genotypes were constructed with the pro-
posed algorithm. The scores were computed with adjustment for
the covariate and with no adjustment for the purpose of compar-
ison. Then we used Equation (1) to build the test statistics for all
siblings and applied them into the data-reduction algorithm
with 10-fold crossvalidation to identify the best interactionmodel.
An exhaustive computational search strategy was performed for all
possible one- to ﬁve-locus models in our simulations. The average
crossvalidation consistency and prediction accuracy, as well as the
standard errors of the means (SEMs), were computed on the basis
of 200 simulation replicates. To assess type I error rate and statisti-
cal power, we determined the p value for each simulated predic-
tion accuracy based on its null distribution generated from permu-
tation testing with 1000 replicates. To maintain the correlations
structure of each family, we used the family as the permuting
unit, i.e., randomly shufﬂed the transmitted set and the nontrans-
mitted set in a whole family. Power and type I error rate were
computed on the basis of 200 and 1000 simulations, respectively.
For comparison, we also ran on the same simulated data sets an
MDR-PDT analysis as implemented with a Beta version of the
computer software provided by the authors.15an Journal of Human Genetics 83, 457–467, October 10, 2008 459
Figure 1. Probability-Probability Plot
of Significance Level and Type I Error
Rate
The horizontal axis represents significance
level, a threshold value specified for per-
mutation testing, whereas the vertical
axis is type I error rate, the proportion of
the permutations resulting in p values
equal to and less than the threshold value
in all permutations for a dichotomous phe-
notype (A) and a continuous phenotype
(B). The reference line is the diagonal
line with unit slope through the origin.A Case Study of Nicotine Dependence
To illustrate the utility of the PGMDRmethod proposed above, we
applied it to a real data set to investigate the role of two type 2 taste
receptor genes in nicotine dependence (ND): taste receptor, type 2,
member 16 (TAS2R16 [MIM 604867]) and taste receptor, type 2,
member 38 (TAS2R38 [MIM 607751]). The subjects used in this
study were the African-American (AA) participants who were
part of the U.S. Mid-South Tobacco Family (MSTF) cohort, enrolled
during 1999–2004 for linkage and/or family-based association
studies. Proband smokers were required to be at least 21 years of
age, to have smoked for at least the last 5 years, and to have con-
sumed an average of 20 cigarettes per day for the last 12 months.
All smoker probands selected for inclusion into the current study
had a FTND23 score of 4 or above and nonsmokers were deﬁned as
those who had smoked less than 100 cigarettes in their lifetime.
Once a proband and a full-sib who was also nicotine dependent
(for a majority of our families) were recruited, additional siblings
and parents were included into the study whenever possible, re-
gardless of smoking status. Participants included 1366 individuals
from 402 AA families that ranged in size from 2 to 9 with an aver-
age size of 3.14 (50.75; SD). Average age 5 SD was 39.4 5 14.4
years for the AA participants. Detailed demographic and clinical
characteristics of this sample have been reported elsewhere.24 All
participants provided informed consents. The study protocol,
forms, and procedures were approved by all participating Institu-
tional Review Boards.
DNA was extracted from peripheral blood samples of each
participant via a kit from QIAGEN (Valencia, CA). Three single-
nucleotide polymorphisms (SNPs) in each of two genes, TAS2R16
and TAS2R38, were genotyped. Detailed information on the gene
structures and SNPs is presented in Tables S3 and S4. For DNA
extraction and genotyping information, please refer to one of
our recent reports.25
After examining genotyping quality and excluding possible gen-
otyping errors, nontransmitted genotypes of nonfounders were
derived based on the conditional distribution given the minimal
sufﬁcient statistic. Residual scores of nonfounders were computed
under a null logistic model with gender and age as covariates for
smoking status. Then, the PGMDR analysis was performed with
the statistic computed as in Equation (1). An exhaustive search
strategy and 10-fold crossvalidationwere used for all possible locus
combinations within each gene and between the two genes. The
empirical p values of prediction accuracy were determined by
permutation testing on the basis of 10,000 shufﬂes. The p values
were also obtained via the sign test for prediction accuracy imple-
mented in the MDR software.10460 The American Journal of Human Genetics 83, 457–467, OctobeResults
Computer Simulations
All estimates of type I error rate determined by the permuta-
tion test were very close to the nominal level. For example,
Figure 1 displays probability-probability (P-P) plots of
signiﬁcance level and type I error rate for a dichotomous
phenotype (Figure 1A) and a quantitative phenotype (Fig-
ure 1B) under anantidiagonalmodel20,21with equifrequent
functional alleles. The points on the plots fall on or near the
reference line that goes through the origin and has unit
slope, suggesting that the algorithm gives rise to a correct
type I error rate for an arbitrarily speciﬁed signiﬁcance level.
The type I error rates at the 0.05 signiﬁcance level were
0.052 and 0.049 for the dichotomous and quantitative
phenotypes, respectively. Simulations for other scenarios
also yielded similar P-P plots (datanot shown). These results
were in good agreement with theoretical expectation,
verifying the validity of the proposed test procedure.
Table 1 presents the statistical power and wrongly posi-
tive rate (WPR, the rate that the false null hypothesis is re-
jected by wrong models) for a dichotomous trait under the
simulation scenario of a checkerboard model13,22 with an
MAF of 0.25 from threemethods: MDR-PDT, PGMDRwith-
out adjustment, and PGMDR with adjustment for the co-
variate. We could not make such a comparison for the
quantitative trait because MDR-PDT is applicable only to
Table 1. Comparison of Power and Wrongly Positive Rate
between MDR-PDT, PGMDR without Covariate Adjustment,
and PGMDR with Covariate Adjustment
Method Powera WPRb
MDR-PDT 0.695 0.020
PGMDR without adjustment 0.920 0.000
PGMDR with adjustment 0.995 0.000
The results presented in this table were based on 200 simulations under
a checkerboard model with MAF of 0.25 at both functional loci.
a Power ¼ the proportion of true models significant at 5% level in all
simulations.
b WPR (wrongly positive rate)¼ the proportion of wrong models significant
at 5% level in all simulations.r 10, 2008
Table 2. Comparison of Prediction Accuracy, Crossvalidation Consistency, and Power between PGMDR with Covariate
Adjustment and without Covariate Adjustment
Scenario
With Adjustment (Mean5 SEM)
Powera
Without Adjustment (Mean5 SEM)
PoweraPrediction Accuracy Crossvalidation Consistency Prediction Accuracy Crossvalidation Consistency
Checkerboard Dichotomous
MAF ¼ 0.25 0.5815 0.013 9.9905 0.100 0.995 0.5465 0.011 9.8355 0.769 0.920
MAF ¼ 0.50 0.5765 0.017 9.9005 0.657 0.980 0.5425 0.014 9.7155 0.865 0.830
Checkerboard Quantitative
MAF ¼ 0.25 0.5885 0.011 10.0005 0.000 1.000 0.5695 0.010 9.9955 0.071 0.995
MAF ¼ 0.50 0.5855 0.012 10.0005 0.000 1.000 0.5665 0.011 9.9955 0.071 1.000
Antidiagonal Dichotomous
MAF ¼ 0.25 0.5755 0.017 9.8755 0.634 0.975 0.5445 0.012 9.6705 1.003 0.870
MAF ¼ 0.50 0.5785 0.019 9.9055 0.507 0.965 0.5415 0.014 9.6555 1.054 0.880
Antidiagonal Quantitative
MAF ¼ 0.25 0.5735 0.012 9.9755 0.354 0.995 0.5585 0.011 9.9555 0.322 0.995
MAF ¼ 0.50 0.5785 0.019 9.9055 0.507 0.975 0.5585 0.014 9.9605 0.242 0.770
These results were under the identified best (2-locus) model for dichotomous and quantitative phenotypes.
a Power ¼ the rate of true positives in all simulations at 5% level.dichotomous traits. Out of 200 simulations, at the 5% sig-
niﬁcance level PGMDR both with and without adjustment
never declared a wrong model as the best model, whereas
MDR-PDT did so four times. PGMDR with adjustment
had the highest power, 7.5% and 30.0% higher than
PGMDR without adjustment and MDR-PDT, respectively.
Comparison of the PGMDR with the MDR-PDT demon-
strated that the PGMDR is more powerful than the MDR-
PDT. This might be due in part to loss of samples, because
when parental genotypes are not completely available, the
original MDR-PDT requires informative discordant sib-
pairs with different marker genotypes, and/or the current
MDR-PDT software is inappropriate for handling different
types of pedigrees. It also possibly arises from the unequal
contributions to the statistic from triads and discordant
sib-ships in the MDR-PDT method.
Table 2 shows the prediction accuracy, crossvalidation
consistency, and power of the best (2-locus) model identi-
ﬁed by the PGMDR method with and without covariate
adjustment under various simulation scenarios, for both
dichotomous and quantitative traits. For detailed results
of one- to ﬁve-locus models, please see Tables S1 and S2
for dichotomous and quantitative traits, respectively. Al-
though both methods correctly identiﬁed the true model
(i.e., the correct two-locus model always gave the maxi-
mum prediction accuracies and crossvalidation consisten-
cies; see Tables S1 and S2), the inclusion of the covariate
in PGMDR leads to a substantial increase in prediction
accuracy, crossvalidation consistency, and power. The
PGMDRwith adjustment had, even in the case of a relative
risk of ~1.70, power of 96.5% or above in the four listed
cases, 7.5%, 15%, 10.5%, and 8.5%, respectively, higher
than the counterparts of the PGMDR without adjustment
in the case of the dichotomous phenotype. The simulationThe Ameriresults listed in Table 2 and Table S2 were similar for a quan-
titative trait, that is, PGMDR with adjustment had consis-
tently higher prediction accuracy, crossvalidation consis-
tency, and power as compared to the PGMDR without
covariate adjustment. These results indicate the necessity
for improved prediction ability and statistical power to
consider the inﬂuence of covariate(s) when informative
covariate(s) is (are) present.
Application to Nicotine-Dependence Data
Table 3 presents the best multilocus models for ND within
each gene and across the two genes, along with the corre-
sponding prediction accuracies, crossvalidations, and p
values in African Americans (AAs). There were no signiﬁ-
cantmodels (all p valuesR 0.120) within each of the genes
studied, suggesting that the marginal contribution from
either gene is not remarkable. When considering the two
genes together, however, we identiﬁed a signiﬁcant three-
SNP interaction model (SNPs rs2233989 and rs846664 in
TAS2R16 and SNP rs1726866 in TAS2R38) with prediction
accuracy 0.556, crossvalidation consistency 9, and permu-
tation p value 0.002, indicating an interactive role of
TAS2R16 and TAS2R38 in the etiology of ND. Figure 2 pro-
vides a graphical representation of the interaction patterns
of the identiﬁed model. The distribution of high-risk and
low-risk cells differs across each single locus and can be cap-
tured only under a multidimensional model, which reveals
the orchestral interplay of TAS2R16 and TAS2R38 in affect-
ing ND.
The identiﬁed interactionmodelhasapredictionaccuracy
of 0.556. Although it appears to be small, it is signiﬁcant
and biological meaningful because the prediction
accuracy is calculated as ðTrue positivesþ True negativesÞ=
ðTrue positivesþ False positives þ True negatives þ Falsecan Journal of Human Genetics 83, 457–467, October 10, 2008 461
Table 3. Comparison of Best Multilocus Models, Prediction Accuracies, Crossvalidation Consistencies, and p Values Identified by
PGMDR with Adjustment for Sex and Age within Each Gene and between the Two Genes for ND
Gene No. of Loci Best Model Prediction Accuracy Crossvalidation Consistency p Value
TAS2R16 1 rs846664 0.520 9 0.181
2 rs846664, rs2233989 0.526 8 0.120
TAS2R38 1 rs1726866 0.511 10 0.308
2 rs1726866, rs713598 0.504 5 0.458
TAS2R16, TAS2R38 1 TAS2R16: rs846664 0.520 8 0.187
2 TAS2R16: rs846664; TAS2R38: rs1726866 0.522 6 0.137
3 TAS2R16: rs846664, rs2233989; 0.556 9 0.002
TAS2R38: rs1726866
4 TAS2R16: rs1204014, rs2233989; 0.533 8 0.103
TAS2R38: rs10246939, rs1726866negativesÞ or its variants, where true positives and false
positives are in the high-risk group those who exceed and
those who do not exceed, respectively, the preassigned
threshold that is used to deﬁne the high-risk and low-risk
groups; false negatives and true negatives are those who
exceed and those who do not exceed, respectively, the
threshold in the low-risk group. Thus, the upper limit of
prediction accuracy is determined by the contribution
rate of the factors under consideration, for example, 100%
contribution will result in a prediction accuracy of 100%
whereas 0% contribution will yield a prediction accuracy
of 50%. Considering the fact that smoking is a complex
multifactor behavior and it is highly likely thatmany genes
each with relatively small effect are involved, such predic-
tion accuracy is biologically plausible.
Discussion
Identiﬁcation of gene-gene and/or gene-environment
joint actions is one of the most important and challenging
topics in human genetics and genetic epidemiology. Our
recently developed GMDR method14 represents a promis-
ing tool for detecting such joint actions for population-
based samples of unrelated participants. In this article,we report the development of a pedigree-based GMDR
algorithms that represents an important extension of our
previous work for unrelated-person designs, because
family-based designs that are robust against population
stratiﬁcation and allelic heterogeneity appear to be more
popular in human genetics study. Although the name is
the same for both types of genetic study designs, the algo-
rithm underlying each approach are rather different. Our
PGMDR is based on a conditioning algorithm for comput-
ing the distribution of nontransmitted genotypes given
the minimum sufﬁcient statistic under the null hypothesis
for the sampling strategy and population structure in the
founder population. Through such a conditioning, the
proposed approach is valid, in the sense of resulting in
correct type I error rates, regardless of patterns of popula-
tion admixture and sampling plan, as supported by our
simulation results.
Because the conditioning algorithm is broadly applica-
ble, the PGMDR can be applied to virtually any scenario,
including arbitrary pedigree structures and arbitrary
patterns of missing marker allele information in the
founders/parents. It can ﬂexibly incorporate diverse pedi-
grees irrespective of structure, size, and missing data, and
utilizes all available subjects in the data set of a study. ForFigure 2. The Identified Best Model that Comprises rs2233989 and rs846664 in TAS2R16 and rs1726866 in TAS2R38
In each combinatorial cell, the left bar represents a positive score and the right bar is a negative score. High-risk cells are indicated by
dark shading, low-risk cells by light shading, and empty cells by no shading.
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example, concordant sibs, unaffected offspring in a family,
and subjects with missing genotypes, which are often
encountered in real data sets but are not useful for the
MDR-PDT and the original MDR, do inform our pedigree-
based statistic. Without discarding any samples at hand,
the proposed method is able to take full advantage of the
whole data set and extract more genetic information. Our
simulation comparisons between the PGMDR and the
MDR-PDT algorithms and the ND data set demonstrate
that our proposed algorithm is more powerful, likely
beneﬁting from capitalizing on more of the data.
The proposed approach, in nature, represents a compre-
hensive statistical framework. Within this framework, we
can use a broad category of test statistics that measure the
covariance between the transmission of genotype and
a function of the phenotype, such as the score-like
statistics for quasilikelihood models, so that any kind of
phenotype and multiallelic markers may be examined.
In contrast to the MDR-PDT and the MDR methods that
are restricted to the context of discordant sib-ships and di-
chotomous traits, the proposed approach is ﬂexible
enough to handle diverse phenotypes, categorical, cen-
sored, or continuous. The extension to multivariate phe-
notypes is also straightforward. Furthermore, one of the
most important advantages of the proposed approach is
that it allows adjustment for covariates so that it can in-
crease predictive ability and statistical power by control-
ling confounding effects of covariates. Both the simula-
tions and the application to the ND data set attest to
the claim that our method can increase prediction accu-
racy and statistical power by inclusion of informative
covariates.
Under this broad framework, available combinatory
approaches can be thought of as special cases in various
scenarios. The proposed method is an extension to fam-
ily-based designs of our recent GMDR14 that itself is a gen-
Figure 3. Schematic Representation of
MDR, GMDR, MDR-PDT, and PGMDR
MDR and GMDR are applicable to analysis of
unrelated samples or discordant sib-pairs
that can be thought as case-control sam-
ples matched on the basis of family.
GMDR is an extension of MDR, which can
consider covariate(s) and flexibly handle
a range of phenotypes that can be modeled
by a generalized linear model or quasilike-
lihood function. Their counterparts in the
context of pedigree-based design are
MDR-PDT and PGMDR, respectively.
eralization of the existing unrelated-
person combinatorial approaches
such as MDR, CPM, and RPM. By cap-
italizing on the ‘‘internal controls’’
extracted from family data, we con-
struct a set of perfectly matched cases
and controls and subsequently carry out the GMDR analy-
sis based on the new data set. Thus, the original GMDR can
be viewed as a special case without internal controls. An in-
tuitive comparison among MDR, MDR-PDT, GMDR, and
PGMDR is summarized in Figure 3.
MDR-PDT15 may also be considered as a special case of
the approach advocated here, although its PDT statistic is
not uniformly equivalent to our general statistic. By de-
ﬁning t(yij) ¼ 1 for affected and t(yij) ¼ 1 for unaffected,
our method has the same result as that of MDR-PDT for
data consisting only of either family trios with an af-
fected child or discordant sib-ships. When a pedigree is
a mixture of these two kinds of data structures, nuclear
families (both parents are observed in a family) and sib-
ships (no parents are available), there will be a slight dif-
ference between the two methods because the two kinds
of data contribute differently to the statistic in the MDR-
PDT.15 In the MDR-PDT, the summary statistic is com-
posed of two components, one for nuclear families in
which each child contributes two shares (both transmit-
ted and nontransmitted) to the statistic, and another
for discordant sib-ships in which each child contributes
one share (only the transmitted) to the statistic. For sim-
plicity, we use a case of one locus to illustrate the differ-
ence between the two methods. Consider a pedigree con-
taining a family with parents Aa and Aa, and two
children, both AA and affected, and a discordant sib-
pair (without parents), one aa and affected and the other
AA and unaffected. The PDT statistics for this pedigree are
D(AA) ¼ 1 and D(aa) ¼ 1, whereas our method gives
S(AA) ¼ 0 and S(aa) ¼ 0. Thus, relative to the MDR-
PDT method,15 in which the statistics are separately de-
ﬁned for triads and discordant sib-ships so that they un-
equally contribute to the overall statistic depending on
family type and size, our method treats different family
types coherently.
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The proposed approach has a uniﬁed framework for
coherently handling different family types. Under this
concept, each nonfounder that informs the test statistic
has a set of nontransmitted genotypes as a control. Un-
like the MDR-PDT where there exists an intrinsic difﬁ-
culty for permuting within larger extended pedigrees
with general structures,15 a permutation test is always
easy to perform for pedigrees with arbitrary structure
and arbitrary size by randomly ﬂipping the transmitted
and nontransmitted genotype sets in a pedigree and
thereby preserving in each permuted data set the possible
nonindependence of transmissions across markers and
across nonfounders.
The general statistical framework developed here also
offers great ﬂexibility in the use of different phenotype
coding strategies. Although any phenotype-coding strat-
egy is valid and results in correct type I error rates under
the null hypothesis, some do provide more efﬁcient and/
or sensitive measures of association under the alternative
and the choice of an appropriate coding strategy can sub-
stantially increase test power. Optimal choices for coding
depend on the study design (e.g., only trios in which the
offspring is affected versus a sample that also includes
unaffected persons) and possibly unknown parameters
(e.g., prevalence rate, relative risk, and allele frequency).
We may obtain an approximately optimal coding based
on prior knowledge of the disease. Power simulations
may also provide guideline for the appropriate choice
based on hypothetical scenarios in which the real parame-
ters potentially fall, although it may be difﬁcult to deter-
mine the real parameters exactly.
The illustrative example demonstrates that the pro-
posed method can unveil cryptic interactions between
the genes TAS2R16 and TAS2R38. Biologically, bitterness
perception serves as a warning system that leads humans
to reject substances that are potentially toxic.26 Human
taste receptors, including type 2 taste receptors (TAS2Rs),
are expressed primarily in taste buds of gustatory papillae
on the tongue surface and palate epithelia. Genetic stud-
ies point to diverse taste perception of bitter substances,
as well as overall oral sensitivity, among individuals and
between ethnic groups partly because of polymorphisms
in taste receptor genes.27 For example, several SNPs
within the TAS2R genes, which encode TAS2R proteins,
can characterize ‘‘tasters’’ and ‘‘nontasters.’’28 Polymor-
phisms in TAS2R genes are implicated in variations of
orally related behaviors, including alcohol29 and nico-
tine30 consumption and dependence. Recently, we found
that several polymorphisms in TAS2R genes are poten-
tially implicated in ND 25. Bitter taste receptor genes are
heterogeneously expressed in taste receptor cells and
TAS2Rs compete with each other for shared cellular re-
sources, from biosynthesis to signaling and ultimately
to turnover.31 This indicates that the signiﬁcant
statistical interaction detected in this study may represent
a biological interaction between TAS2R genes. As illus-
trated in this study, the role of TAS2R genes in the etiol-464 The American Journal of Human Genetics 83, 457–467, Octobeogy of ND is complex; further study is required to assess
functional details.
Appendix A: Algorithm for Computation
of the Conditional Distribution
of Nontransmitted Genotypes
The key step involved in the proposed approach is the
computation of the conditional distribution of nontrans-
mitted genotypes given the minimal sufﬁcient statistic
under the null hypothesis for the phenotype distribution
and the parental genotype distribution. When both paren-
tal genotypes are known, the observed phenotypes in all
family members and the parental genotypes constitute
the minimal sufﬁcient statistic, and the conditional distri-
bution of nontransmitted genotypes is straightforward.
When parental genotype data are not completely available,
however, the conditional distribution of the nontransmit-
ted genotype of an offspring is not immediately obvious.
In this appendix, we present an algorithm for computing
the conditional distribution of nontransmitted genotypes
given the minimal sufﬁcient statistics. To some extent,
this algorithm represents an extension of the approach
proposed by Rabinowitz and Laird.16 The difference
between the two is that we consider here the conditional
distribution of nontransimitted genotypes rather than
that of transmitted genotypes as is done in Rabinowitz
and Laird.16 For each pedigree, the observed genotypes of
nonfounders constitute the set of transmitted genotypes
whereas their nontransmitted counterparts form a set of
nontransmitted genotypes. Under the null hypothesis,
each parent is equally likely to transmit either of her/his
marker alleles and all these parental transmissions are
considered to be independent. Thus, if we do not need to
consider the compatibility of nontransmitted genotypes
with the observed genotypes, a set of transmitted geno-
types can be viewed as one of the plausible realizations
of nontransmitted genotypes and the conditional distribu-
tion of transmitted genotypes derived by Rabinowitz and
Laird’s algorithm16 can also represent that of nontransmit-
ted genotypes given the minimal sufﬁcient statistic. Our
algorithm is based on such a concept of equally frequent
transmissions. Both the transmitted and nontransmitted
sets are assumed to come from a hypothetical homogenous
population.
While remaining the framework unaltered in the original
algorithm,16 we deﬁne here all observed traits, typed
marker alleles, and a plausible set of nontransmitted alleles
in a pedigree as an outcome for the pedigree, instead of that
consisting of all observed traits and typed marker alleles.
Similar to that of Rabinowitz and Laird,16 the condition
that characterizes the minimal sufﬁcient statistic under
the null hypothesis is that: if two different outcomes
have the same value of the minimal sufﬁcient statistic,
then for any pattern of founders’ genotypes, either the con-
ditional probabilities of two outcomes given the pattern ofr 10, 2008
founders’ genotypes are both equal to zero, or the ratio of
the conditional probabilities of the outcomes is invariant
to the choice of the pattern of founders’ genotypes. As
pointed out by Rabinowitz and Laird,16 such a minimal
sufﬁcient statistic is not represented as a particular function
of the data, but rather as a partition of the sample space.
The general steps involved in the algorithm for deriving
the minimal sufﬁcient statistic and computing the condi-
tional distribution of nontransmitted genotypes in a pedi-
gree (a nuclear family is a special case) can be summarized
as follows.
(1) Find all the patterns of founder (parent in a nuclear
family) marker genotypes that are compatible with the
observed genotypes.
(2) For each of the patterns of compatible founder
marker genotypes obtained in step (1), ﬁnd the set of
compatible patterns of nontransmitted genotypes in the
pedigree. Find the subset of these compatible patterns
that, together with the observed nonfounders’ genotypes,
have exactly the same compatible patterns of founders’
genotypes as the observed nonfounders’ genotypes.
(3) Find the subset of these compatible patterns found in
step (2) that are compatible with all observed founder and
nonfounder genotypes. Some of the nontransmitted geno-
types may be ﬁxed in this subset whereas the others may
not. Below we call them ﬁxed nontransmitted genotypes
and nonﬁxed nontransmitted genotypes, respectively.
(4) For every pattern of compatible founder genotypes
found in step (1) and for every pattern of nontransmitted
genotypes in the subset found in step (3), compute the
ratio of the geometrical mean of the conditional probabil-
ity of the observed genotypes (pseudo nontransmitted
genotypes) to that of the conditional probability of the
nonﬁxed nontransmitted genotypes in the subset given
the pattern of founders’ genotypes.
(5) For some patterns of nontransmitted genotypes in
the subset found in step (3), the ratios found in step (4)
will be the same for all of the compatible patterns of
founders’ genotypes found in step (1).
(6) The conditional distribution is found by arbitrarily
choosing any of the compatible patterns of founder geno-
types found in step (1) and computing the conditional
probabilities of the patterns of nontransmitted genotypes
given the chosen pattern of founders’ genotypes and given
the set of patterns of nontransmitted genotypes described
in step (5).
The exhaustive results for nuclear families are tabulated
in Tables A1, A2, and A3. Without loss of generality, we
consider only one marker locus, A. Throughout, A1, A2,.,
represent generic marker alleles, and the conﬁgurations of
the observed nonfounder genotypes in the form of sets,
e.g., the notation {A1A2, A1A3} corresponds to a sibship of
arbitrary size with at least one child carrying A1A2 and
one child carrying A1A3, and no other genotypes. To help
readers follow our presentation, we use an example to illus-
trate the steps involved in this algorithm. Consider a child
conﬁguration {A1A1} with a heterozygous parent A1A2. TheThe Americompatible patterns of the parents are A1A23 A1A1, A1A23
A1A2, and A1A2 3 A1A3 found in step (1). The patterns of
nontransmitted genotypes, {A1A1}, {A1A2}, {A1A1, A1A2}, to-
gether with the observed set {A1A1}, have the compatible
patterns of founders’ genotypes A1A23 A1A1, A1A23 A1A2,
and A1A2 3 A1A3. Only the pattern of nontransmitted
genotypes {A1A2} is found in step (3), i.e., they are ﬁxed.
Finally, we obtain a conditional distribution of the
nontransimtted conﬁguration {A1A2} with probability 1 as
a result of the algorithm.
Table A1. Conditional Distribution of Nontransmitted
Genotypes when One Homozygous A1A1 Parent’s Genotype
and Children’s Genotypes Are Available at Marker Locus A
Children’s Genotype Configuration Transmitted Nontransmitted
{A1A1} A1A1 A1A1
{A1A2} A1A2 A1A2
{A1A1, A1A2} A1A1 A1A2
A1A2 A1A1
{A1A2, A1A3} A1A2 A1A3
A1A3 A1A2
A default implies a conditional probability of 1.
Table A2. Conditional Contribution of Nontransmitted
Genotypes when One Heterozygous A1A2 Parent’s Genotype
and Children’s Genotypes Are Available at Marker Locus A
Children’s Genotype
Configuration Transmitted Nontransmitted
{A1A1} A1A1 A1A2
{A1A2} A1A2 A1A2
{A1A3} A1A3 A2A3
{A1A1, A1A2} A1A1 A1A2
A1A2 random assignment
of A1A1 and A1A2 that
keeps the number of
each proportional to
that in the observed set
{A1A3, A2A3} A1A3 A2A3
A2A3 A1A3
{A1A1, A2A2} or A1A1 A2A2
{A1A1, A1A2, A2A2} A1A2 A1A2
A2A2 A1A1
{A1A1, A1A3}, {A1A1, A2A3}, A1A1 A2A3
{A1A1, A1A2, A1A3}, A1A2 A1A3
{A1A1, A1A2, A2A3}, A1A3 A1A2
{A1A1, A1A3, A2A3} or A2A3 A1A1
{A1A1, A1A2, A1A3, A2A3}
{A1A2, A1A3} or
{A1A2, A1A3, A2A3}
A1A2 randomly assign A1A3 and
A2A3 with probabilities
0.5 and 0.5, independently
to each sib
A1A3 A1A2
A2A3 A1A2
{A1A3, A2A4}, A1A3 A2A4
{A1A3, A1A4}, A1A4 A2A3
{A1A3, A1A4, A2A3} or A2A3 A1A4
{A1A3, A1A4, A2A3, A2A4} A2A4 A1A3
Note: {A1A3, A1A4, A2A4}, {A1A3, A2A3, A2A4}, and {A1A4, A2A3, A2A4} are
configurations equivalent to {A1A3, A1A4, A2A3} because A1, A2, A3, and
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Appendix B: A Schematic Illustration
of the Pedigree-Based GMDR Algorithm
We brieﬂy use Figure S1 to illustrate the steps involved in
conducting the pedigree-based GMDR method. Without
loss of generality, we consider here a classic TDT design
in which each family consists of an affected child and
both parents. To focus on exposition of the data-reduction
algorithm, we assume in Figure S1 no covariate and take
t(yij) ¼ 0.5 for affected children, although we can use any
appropriate statistic instead of this, as deemed necessary.
From Equation (1), all the transmitted genotypes in infor-
mative family triads constitute cases whereas the nontrans-
mitted genotypes serve as artiﬁcial internal controls, thus
constituting a balanced case-control sample. In Step 1,
the pairs of the transmitted and nontransmitted genotypes
are randomly split into some number of equal parts for
crossvalidation; as an illustration, 10-fold crossvalidation
is used in Figure S1. One subdivision is used as the testing
set and the rest as the independent training set. Then,
Steps 2 through 5 are run for the training set and Step 6
Table A3. Conditional Contribution of Nontransmitted
Genotypes when Only Children’s Genotypes Are Available
at Marker Locus A
Children’s Genotype
Configuration Transmitted Nontransmitted
{A1A1} A1A1 A1A1
{A1A2} A1A2 A1A2
{A1A1, A1A2} A1A1 A1A2
A1A2 random assignment of A1A1
and A1A2 that keeps the
number of each proportional
to that in the observed set
{A1A1, A2A2} or A1A1 A2A2
{A1A1, A1A2, A2A2} A1A2 A1A2
A2A2 A1A1
{A1A2, A1A3} A1A2 A1A3
A1A3 A1A2
{A1A3, A2A4} A1A3 A2A4
A2A4 A1A3
{A1A1, A2A3}, A1A1 A2A3
{A1A1, A1A2, A1A3}, A1A2 A1A3
{A1A1, A1A2, A2A3} or A1A3 A1A2
{A1A1, A1A2, A1A3, A2A3} A2A3 A1A1
{A1A2, A1A3, A2A3} A1A2 randomly assign A1A2, A1A3,
and A2A3 with probabilities
1/3, 1/3, and 1/3
independently to each sib
A1A3 randomly assign A1A2, A1A3,
and A2A3 with probabilities
1/3, 1/3, and 1/3
independently to each sib
A2A3 randomly assign A1A2, A1A3,
and A2A3 with probabilities
1/3, 1/3, and 1/3
independently to each sib
{A1A3, A1A4, A2A3} or A1A3 A2A4
{A1A3, A1A4, A2A3, A2A4} A1A4 A2A3
A2A3 A1A4
A2A4 A1A3466 The American Journal of Human Genetics 83, 457–467, Octobefor the testing set. (To reduce the ﬂuctuations resulting
from chance divisions of the data, Steps 2 through 6 are re-
peated in turn for each possible crossvalidation and the re-
sults are averaged. The consistency of the model across
crossvalidation training sets, i.e., how many times the
same MDR model is identiﬁed in all the possible training
sets, is also evaluated.) In Step 2, a set of n genetic and/or
discrete environmental factors is selected from the list of
all factors. In Step 3, the possible multifactor classes or cells
deﬁned by the n factors are represented in n-dimensional
space. Then, the sum of statistic values is calculated within
each multifactor cell. In Step 4, each multifactor cell in
n-dimensional space is labeled as either ‘‘high risk’’ if the av-
erage of the statistic values meets or exceeds a preassigned
threshold T (e.g., T ¼ 0), ‘‘low risk’’ if the threshold is not
exceeded, or ‘‘empty’’ otherwise. A model is formulated
by pooling high-risk cells into one group and low-risk cells
into another group. In Step 5, all potential combinations
of n factors are evaluated sequentially for their ability to
classify statistic values in the training data and the best
n-factor model that yields minimummisclassiﬁcation error
is chosen. In Step 6, the independent testing set is used to
estimate the prediction error of the best model selected
from Step 5. Finally, among this set of best models, we
pick the model that has minimum prediction error and/or
maximum crossvalidation consistency. We can use a sign
test and/or a permutation test for prediction accuracy to
assess the signiﬁcance of an identiﬁed model.
Supplemental Data
Supplemental Data include one ﬁgure and four tables and can be
found with this article online at http://www.ajhg.org/.
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